Blog - INTERNET MÉDICA

■ What sexual behaviors to decreased sexual desire in women? A review and proposal for end points in treatment trials for hypoactive sexual desire disorder

Robert Pyke, Anita Clayton

Sex Med. 2017 Jun; 5(2): e73–e83

http://www.smoa.jsexmed.org/issue/S2050-1161(15)X0002-X

■ What is the real impact of urinary incontinence on female sexual dysfunction? A case control study

Mariana Rhein Felippe, Joao Paulo Zambon, Marcia Eli Girotti et al

Sex Med. 2017, vol 5(1): e54–e60

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302384/

■ Female urinary incontinence and sexuality

Mota RL.

Int Braz J Urol. 2017 Jan-Feb;43(1):20-28

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293379/

■ The effect of extended release tolterodine used for overactive bladder treatment on female sexual function

Athanasios Zachariou, Maria Filiponi

Int Braz J Urol. 2017, vol 43(4): 713–720

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557448/

■ Sexual distress and quality of life among women with bipolar disorder

Sørensen T, Giraldi A, Vinberg M.

Int J Bipolar Disord. 2017 Dec;5(1):29

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461226/

■ Anatomic sites and associated clinical factors for deep dyspareunia

P J Yong, C Williams, A Yosef et al

Sexual Medicine 2017, vol 5 (3): e184-e195

http://www.smoa.jsexmed.org/article/S2050-1161(17)30039-9/fulltext

■ Sexual life of women with Mayer-Rokitansky-Küster-Hauser syndrome after laparoscopic Vecchietti vaginoplasty

Z Pastor, J Fronek, M Novácková, R Chmel

Sexual Medicine 2017, vol 5 (2): e106-e113

http://www.smoa.jsexmed.org/article/S2050-1161(17)30016-8/fulltext

■ Vaginismus treatment: clinical trials follow up 241 patients

P T Pacik, S Gelletta

Sexual Medicine 2017, vol 5 (2): e114-e123

http://www.smoa.jsexmed.org/article/S2050-1161(17)30018-1/fulltext

■ A meta-analysis detailing overall sexual function and orgasmic function in women undergoing miduretheral sling surgery for stress incontinence

N Szell, B Komisaruk, S W Goldstein et al

Sexual Medicine 2017, vol 5 (2): e84-e93

http://www.smoa.jsexmed.org/article/S2050-1161(17)30012-0/fulltext

■ New development in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin

Christopher J Jayne, Michael J Heard, Sarah Zubair, Dustie L Johnson

Int J Womens Health. 2017; 9: 171–178.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396928/

■ The women´s EMPOWER survey: identifying women´s perceptions on vulvar and vaginal atrophy and its treatment

S A Kingsberg, M Krychman, S Graham et al

The Journal of Sexual Medicine 2017, vol 14 (3): 413-424

http://www.jsm.jsexmed.org/article/S1743-6095(17)30058-9/fulltext

■ Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA Study

D J Portaman, L Brown, J Yuan et al

The Journal of Sexual Medicine 2017, vol 14 (6): 834-842

http://www.jsm.jsexmed.org/article/S1743-6095(17)30431-9/fulltext

■ The women´s EMPOWER survey: women´s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate

M Krychman, S Graham, B Bernick et al

The Journal of Sexual Medicine 2017, vol 14 (3): 425-433

http://www.jsm.jsexmed.org/article/S1743-6095(17)30059-0/fulltext

■ Reasons for and experiences with surgical interventions for female genital mutilation/cutting (FGM/C): a systematic review

R C Berg, S Taraldsen, M A Said et al

The Journal of Sexual Medicine 2017, vol 14 (8): 997-990

http://www.jsm.jsexmed.org/article/S1743-6095(17)31266-3/fulltext

■ Impact of ospemifene on quality of life and sexual function in young survivors of cervical cancer: a prospective study

N De Rosa, G Lavitola, P Giampaolino et AL

BioMed Research International 2017 (2017), Article 75136110, 8 pages

https://www.hindawi.com/journals/bmri/2017/7513610/

■ Prevalência de dispareunia na gravidez e fatores associados

Sperandio, Fabiana Flores et al.

Rev. Bras. Saude Mater. Infant., Mar 2016, vol.16, no.1, p.49-55

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292016000100049&lng=en&nrm=iso

■ Are depression and poor sexual health neglected comorbidities? Evidence from a population sample

Field N, Prah P, Mercer CH, Rait G et al

BMJ Open. 2016, vol 6(3):e010521

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809090/

■ Indicadores clínicos de disfunção sexual em mulheres grávidas: revisão integrativa de literatura

Carteiro, Dora Maria Honorato, Sousa, Lisete Maria Ribeiro de and Caldeira, Sílvia Maria Alves

Rev. Bras. Enferm., Fev 2016, vol.69, no.1, p.165-173

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672016000100165&lng=pt&nrm=iso

■ Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort pilot study

S H Oakley, J Walther-Liu, C C Crisp, R N Pauls

Sexual Medicine 2016 (4): e176-e181

http://www.smoa.jsexmed.org/article/S2050-1161(16)00032-5/fulltext

■ The sexual impact of infertility among women seeking fertility care

W D Winkelman, P P Katz, J F Smith

Sexual Medicine 2016, vol 4 (3): e190-e197

http://www.smoa.jsexmed.org/article/S2050-1161(16)30022-8/fulltext

■ Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist

Stacy Tessler Lindau, Emily M. Abramsohn, Shirley R. Baron et al

CA Cancer J Clin. 2016 May; 66(3): 241–263

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860140/

■ The sexual acceptability of contraception: reviewing the literature and building a new concept

Jenny A. Higgins, Nicole K. Smith

J Sex Res. 2016 May 3; 53(4-5): 417–456

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868075/

■ A biopsychosoial approach to women´s sexual function and dysfunction at midlife: a narrative review

Holly N. Thomas, Rebecca C. Thurston

Maturitas. 2016 May; 87: 49–60.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808247/

■ Increasing women´s sexual desire: the comporative effectiveness of estrogens and androgens

Maurand Cappelletti, Kim Wallen

Horm Behav. 2016 Feb; 78: 178–193

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720522/

■ Bremaelanotide for female sexual dysfunction in premenopausal women: a randomized, placebo-controlled dose-finding trial

Anita H Clayton, Stanley E Althof, Sheryl Kingsberg et al

Womens Health (Lond) 2016 Jun; 12(3): 325–337

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384512/

■ Examining the sexual function and related attitudes among women: a cross-sectional study

Safieh Jamali, Afifeh Rahmanian, Shohreh Javadpour

Int J Reprod Biomed (Yazd) 2016 Jan; 14(1): 29–38.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837921/

■ How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer

Sharon L. Bober, Jennifer B. Reese, Lisa Barbera, Andrea Bradford, Kristen M. Carpenter, Shari Goldfarb, Jeanne Carter

Curr Opin Support Palliat Care. 2016 Mar; 10(1): 44–54.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984532/

■ Has testosterone passed the test in premenopausal women with low libido? A systematic review

Beverly G Reed, Laurice Bou Nemer, Bruce R Carr

Int J Womens Health. 2016; 8: 599–607

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066846/

■ Atuação da fisioterapia nas disfunções sexuais femininas: uma revisão sistemática

R E Wolpe, A M Toriv, F P da Silva et al

Acta Fisiátrica 2015, vol 22 (2)

https://www.revistas.usp.br/actafisiatrica/article/view/114510/112337

■ Biopsycholosocial determinants of hypoactive sexual desire in women: a narrative review

Mina Malary, Soghra Khani, Mehdi Pourasghar et AL

Mater Sociomed. 2015 Dec; 27(6): 383–389

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733555/

■ Influência do climatério nas disfunções sexuais em mulheres com doenças reumáticas

Lisboa, Lilian Lira, Andrade, Sandra Cristina de and Azevedo, George Dantas de

Rev. Bras. Reumatol., Abr 2015, vol.55, no.2, p.195-196

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042015000200195&lng=en&nrm=iso

■ Reproduction and mode of delivery in women with vaginismus or localized provoked vestibulodynia: a Swedish register-based study

L Möller, A Josefsson, M Bladh et al

BJOG 2015, vol 122 (3): 329-334

http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.12946/full

■ Sexual desire and hormonal contraception

Ms. Amanda Boozalis, Nhial T. Tutlam, Camaryn Chrisman Robbins, Jeffrey F. Peipert

Obstet Gynecol. 2016, vol 127(3): 563–572

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764410/

■ How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer

Sharon L. Bober, Jennifer B. Reese, Lisa Barbera et al

Curr Opin Support Palliat Care. 2016 Mar; 10(1): 44–54

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984532/

■ Presenting symptoms among Black and White women with provoked vulvodynia

Candace S. Brown, Davis C. Foster, Candi C. Bachour,et al

J Womens Health (Larchmt) 2015 Oct 1; 24(10): 831–836

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841081/

■ Sexual problems among older women by age and race

Anne K. Hughes, Ola S. Rostant, Sally Pelon

J Womens Health (Larchmt) 2015 Aug 1; 24(8): 663–669.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545296/

■ A practical solution for dysparenia in breast cancer survivors: a randomized controlled trial

M F Goetsch, J Y Lim, A B Caughey

J Clin Oncol 2015, vol 33 (30): 3394-3400

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979375/

■ Management of vaginal atrophy: implications from the REVIVE Survey

S Wysocki, S Kingsberg, M Krychman

Clin Med Insights Reprod Health 2014, vol 8: 23-30

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071759/

■ Older women´s sexual desire problems: biopychosocial factors impacting them and barriers to their clinical assessment

Michelle Maciel, Luciana Laganà

Biomed Res Int. 2014; 2014: 107217

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066710/

■ Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterae type 5 inhibitors

Sandra Léa Bonfim Reis, Carmita H. N. Abdo

Clinics (Sao Paulo) 2014 Apr; 69(4): 294–303

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971358/

■ Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence

Nascimento, Elisabete Rodrigues et al.

Clinics, Nov 2013, vol.68, no.11, p.1462-1468

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013001101462&lng=en&nrm=iso

■ Frequência de disfunção sexual em mulheres com doenças reumáticas.

Ferreira, Clarissa de Castro et al.

Rev. Bras. Reumatol., Fev 2013, vol.53, no.1, p.41-46

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042013000100004&lng=en&nrm=iso

■ Sexual activity and satisfaction in healthy community-dwelling older women

Susan E. Trompeter, Ricki Bettencourt, Elizabeth Barrett-Connor

Am J Med. 2012 Jan; 125(1): 37–43.e1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246190/

■ Influência dos sintomas climatéricos sobre a função sexual de mulheres de meia-idade

Cabral, Patrícia Uchôa Leitão et al.

Rev. Bras. Ginecol. Obstet., Jul 2012, vol.34, no.7, p.329-33

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032012000700007&lng=en&nrm=iso

■ Vaginismo

R L B D Moreira

Revista Médica de Minas Gerais 2012, vol 23 (3)

http://rmmg.org/artigo/detalhes/218

■ Gravidez e Diabetes Gestacional: uma combinação prejudicial à função sexual feminina?

Ribeiro, Meireluci Costa et al.

Rev. Bras. Ginecol. Obstet., Maio 2011, vol.33, no.5, p.219-224

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032011000500003&lng=pt&nrm=iso

■ Perfiles e indicadores psicológicos relacionados con la dispareunia y el vaginismo. Estudio cuantitativo. Primera parte

Sánchez Bravo, Claudia et al.

Salud Ment, Ago 2010, vol.33, no.4, p.347-353

http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0185-33252010000400007&lng=pt&nrm=iso

■ Perfiles e indicadores psicológicos relacionados con la dispareunia y el vaginismo: Estudio cualitativo. Segunda parte

Sánchez Bravo, Claudia et al.

Salud Ment, Oct 2010, vol.33, no.5, p.437-449

http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0185-33252010000500008&lng=pt&nrm=iso

■ Efetividade de intervenções fisioterapêuticas para o vaginismo: uma revisão da literatura

Aveiro, Mariana Chaves, Garcia, Ana Paula Urdiales and Driusso,

Fisioter. Pesqui., Set 2009, vol.16, no.3, p.279-283

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1809-29502009000300016&lng=pt&nrm=iso

■ Abordagem fisioterapêutica nas disfunções sexuais femininas.

R S Antonioli, S Simões

Rev Neurocienc 2010, vol 18 (2): 267-274

http://www.revistaneurociencias.com.br/edicoes/2010/RN1802/374%20revisao.pdf

■ Abordagem das disfunções sexuais femininas.

Lara, Lúcia Alves da Silva et al.

Rev. Bras. Ginecol. Obstet., Jun 2008, vol.30, no.6, p.312-321

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032008000600008&lng=en&nrm=iso

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

CRMMG: 7026

Email: pfleite1873@gmail.com

Síndrome do Intestino Irritável Online (Irritable bowel syndrome)

Por Paulo Leite 28/09/2017

■ Updates to the Rome criteria for irritable bowel syndrome

Lin Chang

Gastroenterol Hepatol (N Y) 2017 May; 13(5): 304–306.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479345/

■ Guía de Práctica Clínica: síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos

Mearin, Fermín et al

Rev. esp. enferm. dig., June 2016, vol.108, no.6, p.332-363

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000600007&lng=en&nrm=iso&tlng=es

■ What is new in Rome IV?

Max J Schmulson, Douglas A Drossman

J Neurogastroenterol Motil. 2017 Apr; 23(2): 151–163.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383110/

■ Biomarkers of irritable bowel syndrome

Jae Hak Kim, Eugenia Lin, Mark Pimentel

J Neurogastroenterol Motil. 2017 Jan; 23(1): 20–26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216630/

■ Prevalence, risk factors, and outcomes of irritable bowes syndrome after infectious enteritis: a systematic review and meta-analysis

F Klem, A Wadhwa, L J Prokop et al

Gastroenterology 2017,vol 152 (5): 1042-1054

http://www.gastrojournal.org/article/S0016-5085(17)30008-2/fulltext

■ Assessing the sleep quality and depression-anxiety-stress in irritable bowel syndrome patients

Baniasadi, Nadieh et AL

Arq. Gastroenterol., June 2017, vol.54, no.2, p.163-166

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032017000200163&lng=en&nrm=iso&tlng=en

■ Calidad de vida relacionada con la salud en adultos con síndrome de intestino irritable en un hospital de especialidades de México: estudio transversal.

Sánchez-Cuén, Jaime Alberto et al

Rev. esp. enferm. dig., Apr 2017, vol.109, no.4, p.265-272

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000400005&lng=en&nrm=iso&tlng=es

■ Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet?

Angela Rizzi, Eleonora Nucera, Lucrezia Laterza et al

J Neurogastroenterol Motil. 2017 Jan; 23(1): 101–108

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216640/

■ Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey

Martín Cañón, Alvaro J. Ruiz, Martín Rondón, Jaime Alvarado

Ann Gastroenterol. 2017; 30(1): 67–75

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198249/

■ Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study

Martin Aasbrenn, Ingvild Høgestøl, Inger Eribe et al

BMC Obes. 2017; 4: 22

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490229/

■ Systematic review: the placebo effect of psychological interventions in the treatment of irritable bowel syndrome

Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R van Rood, André J P M Smout, Niek J de Wit

World J Gastroenterol. 2017 Mar 28; 23(12): 2223–2233

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374135/

■ Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice

Susan Lucak, Lin Chang, Albena Halpert, Lucinda A. Harris

Therap Adv Gastroenterol. 2017 , vol 10(2): 253–275

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298476/

■ Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study

Chloé Melchior, Moutaz Aziz, Typhaine Aubry et al

United European Gastroenterol J. 2017, vol 5(2): 261–269

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349360/

■ Irritable bowel syndrome: clinical manifestations, dietary influences and management

Ronald Ikechi, Bradford D. Fischer, Joshua DeSipio, Sangita Phadtare

Healthcare (Basel) 2017, vol 5(2): 21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492024/

■ Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients

Anamaria Cozma-Petruţ, Felicia Loghin, Doina Miere, Dan Lucian Dumitraşcu

World J Gastroenterol. 2017, vol 23(21): 3771–378

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467063/

■ Dietary fiber in irritable bowel syndrome (review)

Magdy El-Salhy, Synne Otterasen Ystad, Tarek Mazzawi, Doris Gundersen

Int J Mol Med. 2017, vol 40(3): 607–613

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548066/

■ Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort

Camille Buscail, Jean-Marc Sabate, Michel Bouchoucha, Marion J. Torres, Benjamin Allès, Serge Hercberg, Robert Benamouzig, Chantal Julia

PLoS One. 2017; vol 12(8): e0183039

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571937/

■ Irritable bowel syndrome and diet

Piero Portincasa, Leonilde Bonfrate, Ornella de Bari et al

Gastroenterol Rep (Oxf) 2017, vol 5(1): 11–1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444258/

■ Dietary triggers in irritable bowel syndrome: Is there a role for glúten?

Umberto Volta, Maria Ines Pinto-Sanchez, Elisa Boschetti,et al

J Neurogastroenterol Motil. 2016 Oct; 22(4): 547–557

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056565/

■ The combination of oligo-and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: results of a randomized, placebo-controlled, double-blind, parallel group, multicentre clinical trial

Octavian Alexea, Vlad Bacarea, Núria Piqué

United European Gastroenterol J. 2016 Jun; 4(3): 455–465

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924437/

■ Comparison of symptoms, healthcare utilization, and treatment in diagnosed and undiagnoses individuals with diarrhea-predominant irritable bowel syndrome

Gregory S Sayuk, Ray Wolf, Lin Chang

Am J Gastroenterol. 2017,vol 112(6): 892–89

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465427/

■ Cognitive-behavioral therapy for patients with irritable bowel syndrome: currents insights

Sarah W Kinsinger

Psychol Res Behav Manag. 2017; vol 10: 231–237.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530860/

■ Psychological interventions for irritable bowel syndrome and inflammatory bowel disease

Sarah Ballou, Laurie Keefer

Clin Transl Gastroenterol. 2017 , vol 8(1): e214

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288603/

■ Sympton burden and consulting behavior in patients with overlapping functional disorders in the US population

Nimish Vakil, Margie Stelwagon, Elizabeth P Shea, Steve Miller

United European Gastroenterol J. 2016 Jun; 4(3): 413–422

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924424/

■ Systematic review: the placebo effect of psychological interventions in the treatment of irritable bowel syndrome

Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R van Rood, André J P M Smout, Niek J de Wit

World J Gastroenterol. 2017, vol 23(12): 2223–2233

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374135/

■ Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

Jessica L. Buono, Robyn T. Carson, Natalia M. Flores

Health Qual Life Outcomes. 2017; vol 15: 35

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310011/

■ High risk of temperomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?

Serena Gallotta, Vincenzo Bruno, Santo Catapano, et al

World J Gastroenterol. 2017 Jan 7; 23(1): 103–109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221272/

■ Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomized controlled trial

H MacPherson, H Tilbrook, D Agbedjro et al

Acupunct Med. 2017, vol 35(1): 17–23

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466911/

■ Targeting histamine receptors in irritable bowel syndrome: a critical appraisal

Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak et AL

J Neurogastroenterol Motil. 2017 Jul; 23(3): 341–348

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503283/

■ Neuroendocrine dysregulation in irritable bowel syndrome patients: a pilot study

Cristina Stasi, Massimo Bellini, Dario Gambaccini, et AL

J Neurogastroenterol Motil. 2017 Jul; 23(3): 428–434

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503293/

■ Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant irritable bowel syndrome: a parallel-group trial

Aelee Jang, Sun-Kyung Hwang, Nikhil S Padhye, Janet C Meininger

J Neurogastroenterol Motil. 2017 Jul; 23(3): 435–445

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503294/

■ Maturation phenotype of peripheral blood monocyte/macrophage after stimulation with lipopolysaccharides in irritable bowel syndrome

riggers in irritable bowel syndrome: Is ther a role for gluten?

Oscar A Rodríguez-Fandiño, Joselín Hernández-Ruiz, Yolanda López-Vidal et al

J Neurogastroenterol Motil. 2017 Apr; 23(2): 281–288

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383123/

■ Balance of autonomic nervous system predicts who benefits from a self-management intervention program for irritable bowel syndrome

Monica E Jarrett, Kevin C Cain, Pamela G Barney et al

J Neurogastroenterol Motil. 2016 Jan; 22(1): 102–11

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699727/

■ Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104: H4: a cohort study with prospective follow-up

Viola Andresen, Bernd Löwe, Wiebke Broicher et al

United European Gastroenterol J. 2016 Feb; 4(1): 121–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766540/

■ Visceral pain perception in patients with irritable syndrome and healthy volunteers is affected by the MRI scanner environment

Reuben K Wong, Lukas Van Oudenhove, Xinhua Li,et al

United European Gastroenterol J. 2016 Feb; 4(1): 132–141

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766539/

■ Update on irritable bowel syndrome diagnostics and therapeutics

Mark Pimentel

Gastroenterol Hepatol (N Y) 2016 Jul; 12(7): 442–445.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969781/

■ Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage

Evangelos J. Giamarellos-Bourboulis, Emmanouel Pyleris, Charalambos Barbatzas, Aikaterini Pistiki, Mark Pimentel

BMC Gastroenterol. 2016; 16: 67

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940948/

■ Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowe syndrome in a clinical study population

Leticia Delgado-Herrera, Kathryn Lasch, Bernhardt Zeiher et al

Therap Adv Gastroenterol. 2017 , vol 10(9): 673–68

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598814/

■ Cytokine and anti-cytokine therapies in preventionor treatment in fibrosis in IBD

Noam Jacob, Stephan R Targan, David Q Shih

United European Gastroenterol J. 2016 Aug; 4(4): 531–540

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971798/

■ Parasitosis y síndrome de intestino irritable.

Ibarra, Catalina et al.

Rev. chil. infectol., Jun 2016, vol.33, no.3, p.268-274

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182016000300003&lng=en&nrm=iso

■ Irritable bowel syndrome subtypes: clinical and psychological features, body mass index and comorbidities